Sign In
Buy CDNA
$38.37
-1.36 (-3.42%)
At Close: Jul 20, 2026
REPEAT - New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy
11:00am, Friday, 20'th Mar 2020
CareDx Congratulates Johns Hopkins on Successful Follow-Up Using AlloSure of First Retransplant Patient After Immunotherapy
CareDx (NASDAQ:CDNA) Sets New 12-Month Low on Insider Selling
05:54am, Friday, 20'th Mar 2020
Shares of CareDx Inc (NASDAQ:CDNA) reached a new 52-week low on Wednesday following insider selling activity. The stock traded as low as $13.04 and last traded at $13.34, with a volume of 437311 share
New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy
05:05am, Friday, 20'th Mar 2020
CareDx, Inc. (CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant pat
New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy
05:05am, Friday, 20'th Mar 2020
CareDx Congratulates Johns Hopkins on Successful Follow-Up Using AlloSure of First Retransplant Patient After Immunotherapy
CareDx Announces New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy
12:00am, Friday, 20'th Mar 2020Spok Appoints Christine Cournoyer to Board of Directors
08:10pm, Thursday, 19'th Mar 2020
Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced that, effective immediately, it has appointed Christine M. Cournoyer, who most recently served as the
ArrowMark Colorado Holdings LLC Has $15.17 Million Holdings in CareDx Inc (NASDAQ:CDNA)
08:42am, Thursday, 19'th Mar 2020
ArrowMark Colorado Holdings LLC raised its holdings in shares of CareDx Inc (NASDAQ:CDNA) by 17.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:14am, Wednesday, 18'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novus Therapeutics (NVUS) and CareDx (CDNA) with bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:14am, Wednesday, 18'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novus Therapeutics
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
07:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) …
Are Options Traders Betting on a Big Move in CareDx (CDNA) Stock?
02:10pm, Tuesday, 17'th Mar 2020
Investors need to pay close attention to CareDx (CDNA) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in CareDx (CDNA) Stock?
02:10pm, Tuesday, 17'th Mar 2020
Investors need to pay close attention to CareDx (CDNA) stock based on the movements in the options market lately.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff
CareDx Launches RemoTraC: Home-Based Monitoring of Transplant Patients
11:00am, Tuesday, 17'th Mar 2020
CareDx, Inc. (CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant pati
